Cost for QD employees to rent an apartment in Chico, CA. $1,200/month. Please turn off your ad blocker in Quality Digest
Our landlords thank you.
AssurX
Published: Wednesday, February 14, 2018 - 13:01 Recent FDA warning letters indicate that many drug manufacturers do not have their manufacturing in a state of current good manufacturing practices (CGMPs) control. During the first half of 2017, the FDA cited adulterated products and insanitary conditions as the two most common violations in drug manufacturing. Here are four ways an automated quality and compliance management system builds control into the production process with respect to adulteration and potential contamination. Two observations by the FDA note that 1) testing is often done only at the completion of a batch; and 2) deviations found while in production were not corrected or documented properly. The common denominator here is a lack of control during the manufacturing process. Implementing an enterprise quality management system that integrates with other systems (e.g., environmental health and safety, supplier quality, batch management) will share information throughout the entire quality cycle. As a result, any nonconformance, regardless of origin, could initiate a new investigation through rules and workflows. In the record below, the nonconformance in an automated QMS can be initiated by another system (a supplier, for example). The two systems communicate with each other and create one master record that becomes a single point of truth. In addition, consolidated reporting available in an EQMS enables trends and risk to be more readily identified. An EQMS with a robust measurements engine can evaluate data and trigger workflows for anything out of specification. Adequate supporting documentation is required to evaluate control standards for all procedures. Without a central source of truth, documentation is unstructured, incomplete, and time-consuming to compile. A common observation by the FDA is lack of complete information for the manufacture of each batch prior to disposition. Consider what happens when a batch deviation is identified. Beyond your processes for ensuring that investigations, corrective actions, and change management are executed efficiently, where is your supporting documentation? A document management system is now a compliance best practice. Furthermore, having an electronic system designed for a QMS platform is the best solution. There are intuitive workflows already in place to automatically launch documents and revisions based on events happening across a quality system. Ultimately, one system contains and controls all records, revisions, and change notifications, which means greater visibility and transparency. The goal of any process should not just be to achieve desired results, but also to improve quality through monitoring systems and process effectiveness. A continual process improvement methodology provides standards for identifying trends and measuring risk. As a result, data may yield areas of concern and opportunities to improve production quality and efficiency. Importing data into your QMS can provide unique insights such as trends and relationships in processes that may not be identified in other, more traditional methods. In the record below, a risk level has been assigned to a deviation. An automated QMS can prioritize records based on risk score. Once dispositioned, signatures can be requested. A corrective action is added as a next step in the nonconformance investigation. A firm is required to prove it is operating within a state of control. Therefore, it must verify that CGMPs are in conformance with regulatory standards. This includes conducting process validation to ensure that submitted data are compliant and useful. In the case of a bone graft manufacturer, the FDA noted a 62-percent failure rate in one batch. A high failure rate demonstrates inconsistent qualification processes that are not in control. Inspectors demand established, documented criteria for approval or rejection of lots or components. In this instance, it’s clear that a discrepancy exists. An automated system would begin an investigation based on the lot rejection. By the end of the investigation, the firm will have statistical findings and documentation of the nonconformance. If necessary, a CAPA will automate correction of the nonconformance and revalidation of the process. Plus, an automated system can trigger any type of impurity study at any time during production to validate reliability of the process. The result is evidentiary proof that the issue is resolved, and the new process is repeatable and meets all CGMPs. Compliance means a firm has established suitable, adequate, and appropriate controls to yield pure and quality product(s). Leveraging a robust QMS platform enables firms to gain control of all aspects of the production process to detect and remedy adulteration. It uses systematic processes to provide evidence that controls are documented, monitored, measured, and reviewed. Integration with multiple systems further extends workflow capabilities and builds a reliable, centralized source that provides a bird’s-eye view into the state of compliance. The end result is more control, unified management, and higher output of consistent, quality product. Quality Digest does not charge readers for its content. We believe that industry news is important for you to do your job, and Quality Digest supports businesses of all types. However, someone has to pay for this content. And that’s where advertising comes in. Most people consider ads a nuisance, but they do serve a useful function besides allowing media companies to stay afloat. They keep you aware of new products and services relevant to your industry. All ads in Quality Digest apply directly to products and services that most of our readers need. You won’t see automobile or health supplement ads. So please consider turning off your ad blocker for our site. Thanks, AssurX Inc. develops quality management and regulatory compliance software solutions to help companies in any industry exceed quality expectations, ensure compliance, manage risks, and better govern their enterprise. AssurX solutions securely handle manufacturing defects, complaints, change control, regulatory compliance, supplier quality, audits, risk, corrective and preventive actions, and more.How to Leverage an EQMS for Managing Product Adulteration
A document management system is now a compliance best practice
1. Integrate EQMS to improve control
Sample automated nonconformance record2. Implement an integrated document management system
3. Build risk management into the system
Automated risk measurement identifies and prioritizes critical events.4. Conduct routine validation
Conclusion
Our PROMISE: Quality Digest only displays static ads that never overlay or cover up content. They never get in your way. They are there for you to read, or not.
Quality Digest Discuss
About The Author
AssurX
© 2023 Quality Digest. Copyright on content held by Quality Digest or by individual authors. Contact Quality Digest for reprint information.
“Quality Digest" is a trademark owned by Quality Circle Institute, Inc.